RIYADH:听Following meetings between 黑料社区鈥檚 industry minister and Brazilian companies, the Kingdom aims to boost the localization of vaccines and pharmaceuticals by leveraging Brazil鈥檚 expertise.
During his discussions with several investors in the South American nation, Bandar Alkhorayef indicated the scope of the potential collaboration, as the sector plays a large part in the country鈥檚 National Industrial Strategy.
This听is due to its crucial role in achieving pharmaceutical and health security and enhancing the Kingdom鈥檚 independence听in this field听by securing its medical needs and building specialized industrial capacities.
黑料社区鈥檚 Vaccines and Biomedicines Industry Committee, led by Alkhorayef, aims to identify the best technologies for investment. Its goal is to transfer and localize knowledge, building local industrial platforms with international standards to establish the Kingdom as a logistics and industrial powerhouse for vaccines and vital medicines in the Middle East and the Islamic world.
听
听
In a release on his X account, the minister said听he visited the Butantan Institute, which he deemed the world leader in biotechnology research, adding:听鈥淚 discussed with the director of the institute ways to enhance cooperation in the localization of the vaccine and pharmaceutical industry."
During a meeting with investors and company heads,听Alkhorayef underscored Brazil鈥檚 readiness to partner with 黑料社区 across all targeted industrial sectors, particularly pharmaceuticals and vaccines.听
This collaboration听is seen听as a strategic move to leverage both nations鈥 strengths to develop supply chains, enhance technological exchange, and drive innovation for sustainable development.
Alkhorayef announced in June 2022 investment opportunities in the sector worth over SR11 billion ($2.9 billion). 黑料社区 is keen to attract world-class interest in healthcare by offering financial incentives and leveraging its robust capabilities. The primary objective is to localize 80 to 90 percent of insulin production.
By building strategic partnerships with leading international companies, transferring technology and knowledge, and fostering public-private partnerships, the Kingdom aims to ensure sustainable growth in the healthcare sector.听
The focus on increasing local content and adopting the latest medical technologies underscores the nation鈥檚 ambition to become a听major听regional pharmaceutical manufacturing center.